These medications belong to a class called GLP-1 receptor agonists
FIGURE 9 Summary and conclusions: Glutathione and early (premature) inflammaging Chronic inflammatory diseases especially those compromising the lower respiratory system (chronic obstructive pulmonary disease, lower respiratory infections, cystic fibrosis, idiopathic pulmonary fibrosis, acute respiratory distress syndrome), diseases compromising the cardiovascular system (atherosclerosis, ischemic heart disease, stroke, and others), many other systemic inflammatory diseases like diabetes (274, 275)
Stylized vial for marketing purposes only
This can be risky for patients, as unapproved versions do not undergo FDAs review for safety, effectiveness and quality before they are marketed, the website states